<DOC>
	<DOCNO>NCT00276848</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , fludarabine cyclophosphamide , work different way stop growth cancer cell , either kill cell stop dividing . It yet know whether give fludarabine together cyclophosphamide effective fludarabine alone treat chronic lymphocytic leukemia . PURPOSE : This randomized phase III trial study give fludarabine together cyclophosphamide see well work compare fludarabine alone treat patient advance chronic lymphocytic leukemia .</brief_summary>
	<brief_title>Fludarabine With Without Cyclophosphamide Treating Patients With Advanced Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare progression-free survival , well overall survival duration remission patient previously untreated , advance chronic lymphocytic leukemia treat fludarabine versus without cyclophosphamide . Secondary - Compare incidence side effect quality life patient treat drug . OUTLINE : This multicenter , randomize study . Patients randomize 1 2 treatment arm - Arm I : Patients receive fludarabine IV day 1-5 . - Arm II : Patients receive fludarabine IV cyclophosphamide IV day 1-3 . In arm , treatment repeat every 28 day 6 course absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 375 patient accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Confirmed diagnosis previously untreated chronic lymphocytic leukemia ( CLL ) Binet stage C stage B acceptable rapid disease progression , symptom enlarge lymph node organ , severe Bsymptoms Binet stage A acceptable , Bsymptoms PATIENT CHARACTERISTICS : ECOG performance status 02 Life expectancy &gt; 6 month No severe organ dysfunction No previous concurrent neoplasm , autoimmune hemolytic anemia , thrombocytopenia PRIOR CONCURRENT THERAPY : No prior concurrent chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>stage III chronic lymphocytic leukemia</keyword>
	<keyword>stage IV chronic lymphocytic leukemia</keyword>
</DOC>